Skip to main content
. 2012 Aug 1;18(8):BR293–BR298. doi: 10.12659/MSM.883261

Figure 2.

Figure 2

Ginkgolic acid inhibits HIV protease activity in a concentration-dependent manner. Recombinant HIV-1 HXB2 KIIA protease and the EnzoLyte™ 520 HIV-1 protease assay kit (AnaSpec Co.) were used in this study. HIV protease inhibitor ritonavir (10.8 μg/ml or 15 μM) was used as a positive control. Ginkgolic acid (32.2, 62.6 and 125 μg/ml) and ginkgolide A (100 μg/ml) were used. ** P<0.01 and * P<0.05 as compared with the negative control (DMSO).